Serious adverse events and death associated with treatment using long-acting β-agonists

Author： Martinez Fernando  

Publisher： Humana Press, Inc

ISSN： 1080-0549

Source： Clinical Reviews in Allergy and Immunology, Vol.31, Iss.2-3, 2006-06, pp. : 269-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of mast cells by β-agonists

By Peachell Peter  

Clinical Reviews in Allergy and Immunology, Vol. 31, Iss. 2-3, 2006-06 ,pp. : 131-141

Humana Press, Inc

Access to resources Recommend Favorite

The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma

By Mansfield Lyndon E.  

Allergy and Asthma Proceedings, Vol. 29, Iss. 2, 2008-03 ,pp. : 103-108

OceanSide Publications, Inc

Access to resources Recommend Favorite

Defining the Effects of an Inhaled Corticosteroid and Long-Acting β-Agonist on Therapeutic Targets

By Settipane Russell A.  

Allergy and Asthma Proceedings, Vol. 24, Iss. 2, 2003-03 ,pp. : 85-89

OceanSide Publications, Inc

Access to resources Recommend Favorite

Controversies and Adverse Reactions to β-Adrenergic Agonists

By Sly R. Michael  

Allergy and Asthma Proceedings, Vol. 14, Iss. 3, 1993-05 ,pp. : 175-179

OceanSide Publications, Inc

Access to resources Recommend Favorite

Adverse Reactions Associated with Parenteral Beta Agonists: Serum Potassium Changes

By Spector Sheldon L.  

Allergy and Asthma Proceedings, Vol. 8, Iss. 5, 1987-09 ,pp. : 317-321

OceanSide Publications, Inc

Access to resources Recommend Favorite